Triglycerides and Heart Health: Reducing Cardiovascular Risk in Type 2 Diabetes
This satellite symposium is supported by an independent educational grant from Amarin Corporation.
Chair: Handrean Soran, Manchester
Speakers: Naresh Kanumilli, Manchester and Christopher Byrne, UK
Join us for an interactive satellite symposium exploring the residual cardiovascular risk in patients with type 2 diabetes with elevated triglycerides. Gain insights into the role of icosapent ethyl, review the latest clinical trial data and learn practical strategies for integrating this therapy into lipid-modification regimens. Featuring expert insights from leading endocrinologists and cardiologists, the session will also include real-world case studies and a Q&A.
Please note that this session is eligible for accreditation.